Malignant leptomeningeal tumor
MONDO:0003762A primary or metastatic malignant tumor involving the leptomeninges.
Also known as: cancer of leptomeninx, leptomeninx cancer, malignant leptomeningeal neoplasm, malignant leptomeningeal tumor, malignant leptomeninx neoplasm, malignant neoplasm of leptomeninx, malignant tumor of leptomeninges, leptomeningeal cancer
2771 clinical trials for this condition and its sub-types, 3 tagged with Malignant leptomeningeal tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Malignant leptomeningeal tumor
-
Leptomeningeal melanoma 1 trial
2 sub-types
- Adult leptomeningeal melanoma 0 trials
- Pediatric leptomeningeal melanoma 0 trials
-
Leptomeningeal sarcoma 0 trials
-
New hope for brain lining cancer: immunotherapy injected directly into spinal fluid
Disease control OngoingThis early-phase trial is testing whether the immunotherapy drug nivolumab can help people with melanoma or lung cancer that has spread to the leptomeninges (the lining of the brain and spinal cord). The drug is given both through a vein and directly into the spinal fluid via a l…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat lung cancer
Disease control OngoingThis early-phase trial is testing two oral drugs, Sapanisertib and Telaglenastat, in 22 people with advanced non-small cell lung cancer that has spread to the brain or other organs. The drugs work by blocking key enzymes that cancer cells need to grow. The main goal is to find th…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC